Association of clinicopathologic parameters with the expression of inducible nitric oxide synthase and vascular endothelial growth factor in mucoepidermoid carcinoma

Oral Diseases

Volumn 17, Issue 6, 2011, Pages 590-596

  Ke Xiong, Ou Yang ^a   Jun, Liang ^b   Zhi Quan, Huang ^b  

^a STOMATOLOGY HOSPITAL OF GUANGZHOU MEDICAL UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Inducible nitric oxide synthase; Mucoepidermoid carcinoma; Vascular endothelial growth factor

Indexed keywords

CD34 ANTIBODY; INDUCIBLE NITRIC OXIDE SYNTHASE; PEROXIDASE; STREPTAVIDIN; VASCULOTROPIN;

ADENOSQUAMOUS CARCINOMA; ANGIOGENESIS; ARTICLE; CANCER PATIENT; CANCER RELAPSE; CANCER SIZE; CANCER STAGING; CELL DIFFERENTIATION; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MICROVASCULATURE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SALIVARY GLAND; STAINING; TUMOR DIFFERENTIATION;

ADULT; ANTIGENS, CD34; CAPILLARIES; CARCINOMA, MUCOEPIDERMOID; CELL DIFFERENTIATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MICROVESSELS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; NITRIC OXIDE SYNTHASE TYPE II; RETROSPECTIVE STUDIES; SALIVARY GLAND NEOPLASMS; SALIVARY GLANDS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 79960700464     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2011.01813.x     Document Type: Article

References (30)

1. Bradley PJ (2001). Distant metastases from salivary glands cancer. ORL J Otorhinolaryngol Relat Spec 63: 233-242.
2. Brandwein MS, Ivanov K, Wallace DI (2001). Mucoepidermoid carcinoma: a clinicopathologic study of 80 patients with special reference to histological grading. Am J Surg Pathol 25: 835-845.
3. Brennan PA, Umar T, Wilson AW et al (2002). Expression of type 2 nitric oxide synthase and vascular endothelial growth factor in oral dysplasia. J Maxillofac Oral Surg 60: 1455-146.
4. Bussolino F, Mantovani A, Persico G (1997). Molecular mechanisms of blood vessel formation. Trends Biochem Sci 22: 251.
5. Chen WL, Zeng SG, Li HG et al (2002). Expression of inducible nitric oxide synthase mRNA in squamous cell carcinoma of tongue. Ai Zheng 21: 314-318.
6. Chen WL, Ouyang KX, Li HG et al (2009). Expression of Inducible Nitric Oxide Synthase and Vascular Endothelial Growth Factor in Ameloblastoma. J Craniofac Surg 20: 171-175.
7. Connelly ST, Macabeo-Ong M, Dekker N et al (2005). Increased nitric oxide levels and iNOS over-expression in oral squamous cell carcinoma. Oral Oncol 41: 261-267.
8. Folkman J, Shing Y. (1992). Angiogenesis. J Biol Chem 267: 10931-10934.
9. Franchi A, Massi D, Santucci M et al (2006). Inducible nitricoxide synthase activity correlates with lymphangiogenesis and vascular endothelial growth factor-C expression in head and neck squamous cell carcinoma. J Pathol 208: 439-445.
10. Garcia-Cardena G, Folkman J. (1998). Is there a role for nitric oxide in tumor angiogenesis? J Natl Cancer Inst 90: 560-561.
11. Goode RK, Auclair PL, Ellis GL (1998). Mucoepidermoid carcinoma of the major salivary glands: clinical and histopathologic analysis of 234 cases with evaluation of grading criteria. Cancer 82: 1217-1224.
12. Hompson L (2007). World Health Organization classification of tumours: pathology and genetics of head and neck tumours. Ear Nose Throat J 85: 74.
13. Kaneko T, Zhang Z, Mantellini MG et al (2007). Bcl-2 orchestrates a cross-talk between endothelial and tumor cells that promotes tumor growth. Cancer Res 67: 9685-9693.
14. Kimura H, Weisz A, Kurashima Y et al (2000). Hypoxia response element of the humanvascular endothelial growth factor genemediates transcriptional regulation bynitric oxide:control of hypoxia inducible factor1 activity by nitric oxide. Blood 95: 189-199.
15. Kroll J, Waltenberger J (1998). VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR). Biochem Biophys Res 252: 743-746.
16. Lan Y, Chen WL, Zeng SG et al (2009). Inhibition of VEGF expression in tongue squamous cancer cells via RNA interference silencing of iNOS gene. Int J Oral Maxillofac Surg 38: 369-373.
17. Lee JC, Chow NH, Wang ST et al (2000). Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients. Eur J Cancer 36: 748.
18. Nathan C, Xie QW (1994). Nitric oxide synthase: roles, tolls, and controls. Cell 78: 915-918.
19. Nieves BJ, D'Amore PA, Bryan BA. (2009). The function of vascular endothelial growth factor. Biofactors 35: 332-337.
20. Podar K, Anderson KC. (2005). The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implications. Blood 105: 1383-1395.
21. Podar K, Tai YT, Lin BK et al (2002). Vascular endothelial growth factor induced migration of multiple myeloma cells is associated with beta 1 phosphatidylinositol 3-kinase-dependent PKC alpha activation. J Biol Chem 277: 7875-7881.
22. Rajkumar SV, Kyle RA (2001). Angiogenesis in multiple myeloma.Semin. Oncol 28: 560-564.
23. Regis De Brito Santos I, Kowalski LP, Cavalcante De Araujo V et al (2001). Multivariate analysis of risk factors for neck metastases in surgically treated parotid carcinomas. Arch Otolaryngol Head Neck Surg 127: 56-60.
24. Ria R, Roccaro AM, Merchionne F et al (2003). Vascular endothelial growth factor and its receptors in multiple myeloma. Leukemia 17: 1961-1966.
25. Ribas C, Colleoni GW, Silva MR et al (2004). Prognostic significance of vascular endothelial growth factor immunoexpression in the context of adversestandard prognostic factors in multiple myeloma. Eur J Haematol 73: 311-317.
26. Vakkala M, Kahlos K, Lakari E et al (2006). Inducible nitric oxide synthase expression, apoptosis and angiogenesis in situ and invasive breast carcinoma. Clin Cancer Res 6: 2408-2416.
27. Weidner N (1995). Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol 147: 9-19.
28. Yin P, Qiu XF, Liu ZC (2005). Expression of inductive nitric oxide synthase and vascular endothelial growth factor in colonic carcinoma, and their effects on tumor angiogenesis. Zhonghua Wei Chang Wai Ke Za Zhi 8: 513-535.
29. Zhang J, Peng B, Chen X (2005). Expressions of nuclear factor kappaB, inducible nitric oxide synthase, and vascular endothelial growth factor in adenoid cystic carcinoma of salivary glands: correlations with the angiogenesis and clinical outcome. Clin Cancer Res 11: 7334-7343.
30. Ziche M, Morbidelli L, Choudhuri R et al (1997). Nitric oxide synthase lies downs steam from vascular endothelial growth factor-induced angiogenesis. J Clin Invest 99: 2625-2634.